BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 1656848)

  • 1. Neuropathy associated with monoclonal gammopathies of undetermined significance.
    Gosselin S; Kyle RA; Dyck PJ
    Ann Neurol; 1991 Jul; 30(1):54-61. PubMed ID: 1656848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathies associated with IgG and IgA monoclonal gammopathy.
    Nobile-Orazio E; Casellato C; Di Troia A
    Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):979-87. PubMed ID: 12407307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuropathy associated with dysglobulinemia and monoclonal gammopathy].
    Saito T
    Nihon Rinsho; 1994 Nov; 52(11):2976-83. PubMed ID: 7996697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurological manifestations of monoclonal gammopathies].
    Chassande B; Léger JM
    Rev Prat; 1993 Feb; 43(3):314-6. PubMed ID: 8389055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-neurofilament antibodies in neuropathy with monoclonal gammopathy of undetermined significance produce experimental motor nerve conduction block.
    Stubbs EB; Lawlor MW; Richards MP; Siddiqui K; Fisher MA; Bhoopalam N; Siegel GJ
    Acta Neuropathol; 2003 Feb; 105(2):109-16. PubMed ID: 12536221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgA monoclonal gammopathy of undetermined significance with peripheral neuropathy.
    Mehndiratta MM; Sen K; Tatke M; Bajaj BK
    J Neurol Sci; 2004 Jun; 221(1-2):99-104. PubMed ID: 15178222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance.
    Dyck PJ; Low PA; Windebank AJ; Jaradeh SS; Gosselin S; Bourque P; Smith BE; Kratz KM; Karnes JL; Evans BA
    N Engl J Med; 1991 Nov; 325(21):1482-6. PubMed ID: 1658648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunostaining of skin biopsy adds no diagnostic value in MGUS-associated peripheral neuropathy.
    Al-Zuhairy A; Schrøder HD; Plesner T; Abildgaard N; Sindrup SH
    J Neurol Sci; 2015 Feb; 349(1-2):60-4. PubMed ID: 25582978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to myelin-associated glycoprotein (anti-Mag) in IgM amyloidosis may influence expression of neuropathy in rare patients.
    Garces-Sanchez M; Dyck PJ; Kyle RA; Zeldenrust S; Wu Y; Ladha SS; Klein CJ
    Muscle Nerve; 2008 Apr; 37(4):490-5. PubMed ID: 18236455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyneuropathy associated with IgA monoclonal gammopathy of undetermined significance.
    Simmons Z; Bromberg MB; Feldman EL; Blaivas M
    Muscle Nerve; 1993 Jan; 16(1):77-83. PubMed ID: 8380902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyneuropathy associated with IgM monoclonal gammopathy: a review. Clinical, electrophysiological and pathological features.
    Leger JM; Vaunaize J
    Nouv Rev Fr Hematol (1978); 1990; 32(5):303-6. PubMed ID: 1965990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peripheral neuropathy with monoclonal gammopathy].
    Meier T; Meyer M
    Schweiz Med Wochenschr; 1990 Mar; 120(12):417-25. PubMed ID: 2157280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrodiagnostic patterns in MGUS neuropathy.
    Wilson JR; Stittsworth JD; Fisher MA
    Electromyogr Clin Neurophysiol; 2001; 41(7):409-18. PubMed ID: 11721296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS.
    Suarez GA; Kelly JJ
    Neurology; 1993 Jul; 43(7):1304-8. PubMed ID: 8327128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral neuropathies associated with monoclonal proteins: a clinical review.
    Kelly JJ
    Muscle Nerve; 1985 Feb; 8(2):138-50. PubMed ID: 2997604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal proteins in neuropathy.
    Kyle RA
    Neurol Clin; 1992 Aug; 10(3):713-34. PubMed ID: 1323750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing neuropathies associated with monoclonal gammopathy of undetermined significance (MGUS): a framework consistent with classifying injuries according to fiber size.
    Fisher MA; Wilson JR
    Neurol Clin Neurophysiol; 2002; 2002(3):2-7. PubMed ID: 12028821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of IgM-MGUS and IgG-MGUS polyneuropathy.
    Simovic D; Gorson KC; Ropper AH
    Acta Neurol Scand; 1998 Mar; 97(3):194-200. PubMed ID: 9531437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of polyneuropathy due to IgM monoclonal gammopathy: a prospective cohort study.
    Niermeijer JM; Fischer K; Eurelings M; Franssen H; Wokke JH; Notermans NC
    Neurology; 2010 Feb; 74(5):406-12. PubMed ID: 20124206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polyneuropathies and monoclonal gammopathies, so-called benign].
    Vallat JM; Jauberteau MO; Arbo-Oze-de-Morvil C; Tabaraud F
    Rev Prat; 1992 Jan; 42(1):43-5. PubMed ID: 1314413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.